Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study| (NASDAQ: KRYS) | Delayed: 313.17 +1.67 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $311.50 | 52 Week High | $ | |||
| Open | $313.56 | 52 Week Low | $ | |||
| Day High | $317.76 | P/E | N/A | |||
| Day Low | $312.00 | EPS | $ | |||
| Volume | 41,303 | |||||



